WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation.
about
Dendritic Cell Therapy in an Allogeneic-Hematopoietic Cell Transplantation Setting: An Effective Strategy toward Better Disease Control?Adoptive T-cell therapy for LeukemiaGeneration of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplantT-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapyImproved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein.Generation of tumor antigen-specific T cell lines from pediatric patients with acute lymphoblastic leukemia--implications for immunotherapy.Common Ewing sarcoma-associated antigens fail to induce natural T cell responses in both patients and healthy individuals.Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1(+) leukemias.Adoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells.Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experienceLentivirus-induced dendritic cells for immunization against high-risk WT1(+) acute myeloid leukemia.Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation.Identification of novel myeloma-specific XBP1 peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma.Enumeration of WT1-specific CD8(+) T cells for clinical application using an MHC Streptamer based no-wash single-platform flow-cytometric assay.Detection of relapse after hematopoietic stem cell transplantation in childhood by monitoring of WT1 expression and chimerism.
P2860
Q26830857-6A8789A6-E923-4EEE-81AD-815BBAE2C021Q27006934-480E4FCB-0588-44DE-89FF-ADDC9F308E2DQ34635978-509C5D15-AE75-409E-A8A0-0DA4DC5D5792Q34707452-D51971CE-B117-464A-BE82-DF110A89F871Q34792248-9E144082-126E-4F06-BAFE-4F24EF411B6CQ34803707-8E5A3025-8A64-49E2-BAE1-4E1011EAB664Q35196739-76B6548C-1D75-4B64-A8F1-BCBD4A832D7EQ36194241-61669739-15C2-48B8-BEF2-245AB403D84CQ37242561-4C24EBBF-8BBC-4D70-B3A7-D41FF9B8B4AFQ37772085-32A81EAB-9222-47D3-B982-63B7F0471C93Q38318616-1194A4C3-6713-43F0-9EB9-15203B6D7789Q38947873-80BF414B-1601-451F-8148-7170AF9A5B29Q39527323-A0D8C19A-A081-4CD9-8623-EBEA1C1A76A9Q48644166-BF262FF9-0166-4CB0-90BE-1E6CA95F88E0Q53629618-C2A46723-498F-4204-80F3-4FF5055D9B68
P2860
WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
WT1 peptide-specific T cells g ...... eic stem cell transplantation.
@en
WT1 peptide-specific T cells g ...... eic stem cell transplantation.
@nl
type
label
WT1 peptide-specific T cells g ...... eic stem cell transplantation.
@en
WT1 peptide-specific T cells g ...... eic stem cell transplantation.
@nl
prefLabel
WT1 peptide-specific T cells g ...... eic stem cell transplantation.
@en
WT1 peptide-specific T cells g ...... eic stem cell transplantation.
@nl
P2093
P2860
P356
P1433
P1476
WT1 peptide-specific T cells g ...... eic stem cell transplantation.
@en
P2093
A Willasch
E Koscielniak
H Kreyenberg
T Klingebiel
P2860
P2888
P304
P356
10.1038/LEU.2009.70
P577
2009-04-09T00:00:00Z